Editorial: The immunosuppressive microenvironment in pediatric cancers: applications and considerations in immunotherapy.
作者信息
Tan Jiaxiong, Gao Fei, Xu Ling
机构信息
National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Brown Center for Immunotherapy, Indiana University School of Medicine, Indianapolis, IN, United States.
出版信息
Front Oncol. 2025 Mar 18;15:1582467. doi: 10.3389/fonc.2025.1582467. eCollection 2025.
Abstract
摘要
相似文献
1
Editorial: The immunosuppressive microenvironment in pediatric cancers: applications and considerations in immunotherapy.社论：儿童癌症中的免疫抑制微环境：免疫治疗中的应用与考量
Front Oncol. 2025 Mar 18;15:1582467. doi: 10.3389/fonc.2025.1582467. eCollection 2025.
2
Immunosuppressive microenvironment in acute myeloid leukemia: overview, therapeutic targets and corresponding strategies.急性髓系白血病中的免疫抑制微环境：概述、治疗靶点及相应策略
Ann Hematol. 2024 Dec;103(12):4883-4899. doi: 10.1007/s00277-024-06117-9. Epub 2024 Nov 28.
3
Targeting the myeloid microenvironment in neuroblastoma.针对神经母细胞瘤中的骨髓微环境。
J Exp Clin Cancer Res. 2023 Dec 13;42(1):337. doi: 10.1186/s13046-023-02913-9.
4
Single-cell transcriptomic analysis of the immune microenvironment in pediatric acute leukemia.单细胞转录组分析儿科急性白血病的免疫微环境。
Cancer Lett. 2024 Aug 1;596:217018. doi: 10.1016/j.canlet.2024.217018. Epub 2024 Jun 4.
5
Editorial: Immunotherapy in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).社论：急性髓系白血病（AML）和急性淋巴细胞白血病（ALL）中的免疫疗法。
Front Immunol. 2024 Oct 17;15:1501760. doi: 10.3389/fimmu.2024.1501760. eCollection 2024.
6
The immune landscape of neuroblastoma: Challenges and opportunities for novel therapeutic strategies in pediatric oncology.神经母细胞瘤的免疫景观：儿科肿瘤学中新型治疗策略的挑战和机遇。
Eur J Cancer. 2021 Feb;144:123-150. doi: 10.1016/j.ejca.2020.11.014. Epub 2020 Dec 18.
7
The role of the immunosuppressive microenvironment in acute myeloid leukemia development and treatment.免疫抑制微环境在急性髓系白血病发生发展及治疗中的作用
Expert Rev Hematol. 2014 Dec;7(6):807-18. doi: 10.1586/17474086.2014.958464. Epub 2014 Sep 16.
8
Optimizing NK Cell-Based Immunotherapy in Myeloid Leukemia: Abrogating an Immunosuppressive Microenvironment.优化基于自然杀伤细胞的免疫疗法治疗髓系白血病：消除免疫抑制微环境。
Front Immunol. 2021 Jun 17;12:683381. doi: 10.3389/fimmu.2021.683381. eCollection 2021.
9
Advances in immunotherapy for pediatric acute myeloid leukemia.儿童急性髓系白血病免疫治疗的进展
Expert Opin Biol Ther. 2018 Jan;18(1):51-63. doi: 10.1080/14712598.2018.1384463. Epub 2017 Oct 11.
10
Mechanisms of Immunosuppressive Tumor Evasion: Focus on Acute Lymphoblastic Leukemia.免疫抑制性肿瘤逃逸的机制：以急性淋巴细胞白血病为例。
Front Immunol. 2021 Nov 18;12:737340. doi: 10.3389/fimmu.2021.737340. eCollection 2021.
本文引用的文献
1
Progress in immune microenvironment, immunotherapy and prognostic biomarkers in pediatric osteosarcoma.儿童骨肉瘤免疫微环境、免疫治疗及预后生物标志物的研究进展
Front Immunol. 2025 Jan 22;16:1548527. doi: 10.3389/fimmu.2025.1548527. eCollection 2025.
2
A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma.一种由 MYCN 驱动的去分化特征确定了一组侵袭性视网膜母细胞瘤亚群。
Commun Biol. 2024 Jul 30;7(1):919. doi: 10.1038/s42003-024-06596-6.
3
Challenges and opportunities in cancer immunotherapy: a Society for Immunotherapy of Cancer (SITC) strategic vision.癌症免疫治疗的挑战与机遇：癌症免疫治疗学会（SITC）的战略愿景。
J Immunother Cancer. 2024 Jun 19;12(6):e009063. doi: 10.1136/jitc-2024-009063.
4
Pediatric Solid Cancers: Dissecting the Tumor Microenvironment to Improve the Results of Clinical Immunotherapy.儿科实体瘤：剖析肿瘤微环境以改善临床免疫治疗效果。
Int J Mol Sci. 2024 Mar 12;25(6):3225. doi: 10.3390/ijms25063225.
5
IGF2BP1 induces neuroblastoma via a druggable feedforward loop with MYCN promoting 17q oncogene expression.IGF2BP1 通过与 MYCN 促进 17q 癌基因表达的可用药理性正反馈环诱导神经母细胞瘤。
Mol Cancer. 2023 May 29;22(1):88. doi: 10.1186/s12943-023-01792-0.
Zotero 插件